698 related articles for article (PubMed ID: 7911785)
21. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis.
Candolfi E; Hunter CA; Remington JS
Infect Immun; 1995 Mar; 63(3):751-6. PubMed ID: 7868243
[TBL] [Abstract][Full Text] [Related]
22. Downmodulation of Effector Functions in NK Cells upon Toxoplasma gondii Infection.
Sultana MA; Du A; Carow B; Angbjär CM; Weidner JM; Kanatani S; Fuks JM; Muliaditan T; James J; Mansfield IO; Campbell TM; Liu L; Kadri N; Lambert H; Barragan A; Chambers BJ
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760930
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.
Tato CM; Villarino A; Caamaño JH; Boothby M; Hunter CA
J Immunol; 2003 Mar; 170(6):3139-46. PubMed ID: 12626571
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.
Ge Y; Chen J; Qiu X; Zhang J; Cui L; Qi Y; Liu X; Qiu J; Shi Z; Lun Z; Shen J; Wang Y
Int J Parasitol; 2014 Jun; 44(7):475-84. PubMed ID: 24727091
[TBL] [Abstract][Full Text] [Related]
25. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
Kang H; Remington JS; Suzuki Y
J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
[TBL] [Abstract][Full Text] [Related]
26. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon.
Nguyen TD; Bigaignon G; Markine-Goriaynoff D; Heremans H; Nguyen TN; Warnier G; Delmee M; Warny M; Wolf SF; Uyttenhove C; Van Snick J; Coutelier JP
J Med Microbiol; 2003 Oct; 52(Pt 10):869-876. PubMed ID: 12972580
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-12 enhances murine survival against acute toxoplasmosis.
Khan IA; Matsuura T; Kasper LH
Infect Immun; 1994 May; 62(5):1639-42. PubMed ID: 7909536
[TBL] [Abstract][Full Text] [Related]
28. Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice.
Schlüter D; Deckert-Schlüter M; Schwendemann G; Brunner H; Hof H
Immunology; 1993 Mar; 78(3):430-5. PubMed ID: 8478025
[TBL] [Abstract][Full Text] [Related]
29. A novel 2B4 receptor leads to worse pregnancy outcomes by facilitating TNF-α and IFN-γ production in dNK cells during Toxoplasma gondii infection.
Xu X; Zheng G; Ren Y; He X; Peng B; Hu X; Liu W
Parasit Vectors; 2022 Sep; 15(1):337. PubMed ID: 36153598
[TBL] [Abstract][Full Text] [Related]
30. Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages.
Nakano Y; Hisaeda H; Sakai T; Ishikawa H; Zhang M; Maekawa Y; Zhang T; Takashima M; Nishitani M; Good RA; Himeno K
Microbes Infect; 2002 Jan; 4(1):1-11. PubMed ID: 11825769
[TBL] [Abstract][Full Text] [Related]
31. Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR mice.
Vaillier D; Daculsi R; Legrand E; Guillemain B
Cancer Immunol Immunother; 1989; 29(1):35-42. PubMed ID: 2468413
[TBL] [Abstract][Full Text] [Related]
32. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
Kasper LH; Matsuura T; Khan IA
J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482
[TBL] [Abstract][Full Text] [Related]
33. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.
Denkers EY; Gazzinelli RT; Martin D; Sher A
J Exp Med; 1993 Nov; 178(5):1465-72. PubMed ID: 8228800
[TBL] [Abstract][Full Text] [Related]
34. Role of innate immune cells in protection against Toxoplasma gondii at inflamed site.
Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Himeno K
J Med Invest; 2001 Feb; 48(1-2):73-80. PubMed ID: 11286020
[TBL] [Abstract][Full Text] [Related]
35. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
[TBL] [Abstract][Full Text] [Related]
36. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response.
Ross ME; Caligiuri MA
Blood; 1997 Feb; 89(3):910-8. PubMed ID: 9028322
[TBL] [Abstract][Full Text] [Related]
37. CD8+ T lymphocytes are the major cell population involved in the early gamma interferon response and resistance to acute primary Toxoplasma gondii infection in mice.
Shirahata T; Yamashita T; Ohta C; Goto H; Nakane A
Microbiol Immunol; 1994; 38(10):789-96. PubMed ID: 7869956
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
[TBL] [Abstract][Full Text] [Related]
39. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
[TBL] [Abstract][Full Text] [Related]
40. Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii.
Suzuki Y; Claflin J; Wang X; Lengi A; Kikuchi T
Int J Parasitol; 2005 Jan; 35(1):83-90. PubMed ID: 15619519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
